Life Sciences & Biotech Workflow Automation Assessment on AWS

Life sciences and biotech organizations operate highly complex, data-intensive workflows across clinical trials, research and development (R&D), and regulatory processes. These workflows often rely on manual data review, document interpretation, and fragmented decision-making, resulting in delayed trial execution, longer time-to-market, and increased operational cost. As data volumes grow across clinical systems, lab environments, and regulatory documentation, manual processes cannot scale. Delays in patient matching, protocol analysis, safety review, and regulatory submission directly impact speed to market, revenue realization, and competitive positioning. Compass UOL helps life sciences and biotech organizations assess and modernize their workflow execution by identifying where AI-driven automation can reduce cycle time, improve decision consistency, and accelerate regulated processes. This assessment evaluates current workflows, decision points, data availability, and system dependencies to define a structured automation strategy. Using AWS-native services—including data platforms, AI/ML capabilities, and GenAI services such as Amazon Bedrock—Compass UOL defines how to automate document-heavy and decision-intensive workflows while maintaining compliance, traceability, and control. The result is a clear roadmap to operationalize AI-driven automation across clinical, research, and regulatory processes at scale.

Buyer Problem / Business Trigger

Manual review of clinical, regulatory, and research data slowing decision cycles Delays in clinical trial execution and regulatory submissions High operational cost from document-heavy, human-dependent workflows Inconsistent decision-making across R&D and compliance processes

Delivery Model

Workflow discovery and operational process review Identification of decision points and automation opportunities AWS-native architecture design for AI-driven workflow automation Roadmap for implementation and scaling across regulated environments

Assessment / Engagement Scope

Mapping of workflows across clinical trials, R&D, and regulatory processes Identification of manual review steps and decision bottlenecks Evaluation of data availability, document formats, and integration points Assessment of compliance, traceability, and auditability requirements Design of AWS-native architecture (data pipelines, AI/ML, GenAI integration) Prioritization of automation use cases based on time-to-impact and regulatory constraints

Expected Output / Deliverables

Workflow automation assessment report AWS reference architecture for life sciences workflow automation Prioritized use cases (clinical data review, document processing, regulatory workflows) Business impact mapping (cycle time reduction, cost savings, decision acceleration) Implementation roadmap for AI-driven workflow automation

Customer Decision Questions This offer helps the customer answer:

Which clinical and regulatory workflows should be automated to reduce time-to-market? How can AI be deployed in regulated environments while maintaining compliance? What AWS architecture supports scalable workflow automation in life sciences?